HNWAG
ICVX

High Net Worth Advisory Group’s Icosavax, Inc. Common Stock ICVX Stock Holding History

High Net Worth Advisory Group’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500
Closed -$3K – 736
2022
Q2 		$3K Hold
500
– – ﹤0.01% 620
2022
Q1 		$4K Buy
+500
New +$7.86K ﹤0.01% 614

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

High Net Worth Advisory Group's ICVX Position: Q3 2022 in Review

High Net Worth Advisory Group sold out of Icosavax, Inc. Common Stock (ICVX) in Q3 2022, closing a stake of 500 shares — an estimated $3K sold.

High Net Worth Advisory Group first reported a position in ICVX in Q1 2022 and held it in 2 quarters. The position peaked at $4K in Q1 2022. 73 funds tracked by Wall St. Rank hold ICVX as of Q3 2022.

  • High Net Worth Advisory Group reported no remaining Icosavax, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 500 Icosavax, Inc. Common Stock shares in Q3 2022, an estimated $3K.
  • High Net Worth Advisory Group first reported a position in Icosavax, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • High Net Worth Advisory Group's Icosavax, Inc. Common Stock position peaked at $4K in Q1 2022.
  • 73 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q3 2022.

Based on High Net Worth Advisory Group's 13F filing for Q3 2022, filed 24 Oct 2022.